A review of clinical, subclinical signs and treatment of primary fallopian tube carcinoma

Abstract

Primary fallopian tube carcinoma is very rare, responsible for 0.14% - 1.8% of genital malignancies. The purpose of this study is to review of the diagnosis, treatment and prognosis of this cancer in National Hospital for Obstetrics and Gynecology from 2011 to 2015. Subjects and methods: retrospective descriptive. Results: Abnormal bloody discharge and abdominal pain are the best common signs (40%). Preoperative serum CA 125 levels average: 715.33 ± 1787.074 U/l. As stage, the IIA accounts for 40%. Only 11 cases received chemotherapy, among them Taxotere + Carboplatin 63.6%. Conclusion: Primary fallopian tube carcinoma is a rare malignancy of the female genital tract. Its preoperative diagnosis is easy to miss or delay because of a lack of specific signs and symtomps. Surgery and chemotherapy provide possibility of disease-free or overall survival.